A readily identifiable biomarker for ß2-agonist use is desperately needed to maintain competition integrity and ensure welfare of performance horses. Our overarching hypothesis is that chronic ß2-agonist administration induces an energetic switch in skeletal muscle, resulting in impaired mitochondrial function and elevated oxidative stress which, in turn, up-regulates a single or group of metabolites that […]
Read More